These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32920971)

  • 1. Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.
    Deguchi H; Morla S; Griffin JH
    J Thromb Haemost; 2021 Jan; 19(1):7-19. PubMed ID: 32920971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.
    Zilberman-Rudenko J; Deguchi H; Shukla M; Oyama Y; Orje JN; Guo Z; Wyseure T; Mosnier LO; McCarty OJT; Ruggeri ZM; Eckle T; Griffin JH
    Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):901-913. PubMed ID: 32102568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.
    Deguchi H; Sinha RK; Marchese P; Ruggeri ZM; Zilberman-Rudenko J; McCarty OJT; Cohen MJ; Griffin JH
    Blood; 2016 Oct; 128(14):1870-1878. PubMed ID: 27421960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.
    Deguchi TK; Deguchi H; Guo Z; Elias DJ; Griffin JH
    Thromb Res; 2020 May; 189():88-92. PubMed ID: 32192996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation.
    Morla S; Deguchi H; Zilberman-Rudenko J; Gruber A; McCarty OJT; Srivastava P; Gailani D; Griffin JH
    J Biol Chem; 2022 Feb; 298(2):101567. PubMed ID: 35007530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.
    Morla S; Deguchi H; Griffin JH
    J Thromb Haemost; 2021 Feb; 19(2):470-477. PubMed ID: 33176060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.
    Novakovic VA; Gilbert GE
    Blood; 2020 Nov; 136(21):2469-2472. PubMed ID: 32604409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.
    Deguchi H; Guo Z; Hayat M; Pflimlin E; Lear S; Shen W; Griffin JH
    J Biol Chem; 2019 Oct; 294(41):15176-15181. PubMed ID: 31481465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full-length plasma skeletal muscle myosin isoform deficiency is associated with coagulopathy in acutely injured patients.
    Coleman JR; Deguchi H; Deguchi TK; Cohen MJ; Moore EE; Griffin JH
    J Thromb Haemost; 2022 Jun; 20(6):1385-1389. PubMed ID: 35253989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of human factor Va inactivation by activated protein C.
    Bravo MC; Orfeo T; Mann KG; Everse SJ
    BMC Syst Biol; 2012 May; 6():45. PubMed ID: 22607732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V and thrombotic disease: description of a janus-faced protein.
    Nicolaes GA; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation.
    Abrams ST; Su D; Sahraoui Y; Lin Z; Cheng Z; Nesbitt K; Alhamdi Y; Harrasser M; Du M; Foley JH; Lillicrap D; Wang G; Toh CH
    Blood; 2021 Jan; 137(1):103-114. PubMed ID: 33410894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin.
    Wiencek JR; Hirbawi J; Yee VC; Kalafatis M
    J Biol Chem; 2016 Jan; 291(4):1565-1581. PubMed ID: 26601957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Tran S; Norstrøm E; Dahlbäck B
    J Biol Chem; 2008 Mar; 283(11):6648-55. PubMed ID: 18198180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
    Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effect of histone H4 on prothrombin activation.
    Pozzi N; Di Cera E
    J Thromb Haemost; 2016 Sep; 14(9):1814-8. PubMed ID: 27359051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired thrombin generation in Reelin-deficient mice: a potential role of plasma Reelin in hemostasis.
    Tseng WL; Chen TH; Huang CC; Huang YH; Yeh CF; Tsai HJ; Lee HY; Kao CY; Lin SW; Liao HR; Cheng JC; Tseng CP
    J Thromb Haemost; 2014 Dec; 12(12):2054-64. PubMed ID: 25255925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.